Announced
Completed
Synopsis
Bioscript, a full-service pharmaceutical communications company, completed the acquisition of Fortis Pharma, a London-based specialist in medical affairs services, and Valid Insight, a pharmaceutical global market access consultancy. Financial terms were not disclosed. “These acquisitions are incredibly exciting. At a time of greater trial complexity, rising evidence demands, and tougher economic conditions our clients are looking to us to help navigate demanding access environments and optimise launch success,” Andrew Medley, Bioscript Group CEO.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.